[Clinical evaluation of SM-4300 against bacterial infections in the field of internal medicine].

A new drug of human intact immunoglobulin, SM-4300 was applied to the acute respiratory infections in the field of internal medicine. SM-4300 was administered intravenously for 1 or 3 days at a daily dose of 2.5 g to 4 patients suffering from respiratory infections. We have obtained the results as follows. Clinical effects of SM-4300 were good in 2 cases, fair in 1 case, unknown in 1 case, and no side effects were observed.